AVAX Technologies, Inc.

Description

Broadly speaking, we use personal information for purposes of administering our business activities, providing customer service and making available other products and services to our customers and prospective customers. Occasionally, we may also use the information we collect to notify you about important changes to our Web site, new services and special offers we think you will find valuable.

Founded in 1988, Cancer Treatment Centers of America (CTCA) provides a comprehensive, patient-centered treatment model that fully integrates traditional, state-of-the-art medical treatments with scientifically-supported complementary therapies such as nutrition, naturopathic medicine, psycho-social counseling, physical therapy and spiritual support to meet the special, whole-person needs of cancer patients living with complex and advanced-stage disease.

Dr. Fourthin comes to AVAX with over thirteen years of experience in the pharmaceutical/biotech industry in Europe. Most recently she was Medical Director, Oncology with Merck & Co., Inc. based in Paris. Previously, she held a Chief Medical Officer Europe position for Ost-Developpement S.A., a subsidiary of Osteotech Inc. - a global biotech and medical device company, and worked for Sanofi-Aventis as a Field Manager.

AVAX TECHNOLOGIES, INC. is a development stage biotechnology company specializing in the commercialization of individualized vaccines for the treatment of cancer. Our vaccine consists of autologous (the patient's own) cancer cells that have been treated with a chemical ("haptenized") to make them more visible to the patient's immune system. We refer to our technology as the autologous cell (AC) vaccine platform. Currently clinical trials for the AC Vaccine have concentrated on melanoma, ovarian carcinoma, which are our primary indications, and non-small cell lung cancer.

Welcome to AVAX Technologies Inc.'s Investor Relations Information Site. We are pleased to provide you with information regarding AVAX Technologies' financial highlights. For your convenience, we provide a library of press releases and prefiltered links to the EDGAR database.

Companies nearby